Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Friis

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
HIV Medicine|January 22, 2011
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*)K Petoumenos, S Worm, P Reiss, et al.
Human Reproduction (Oxford, England)|February 8, 2025
Impact of female age on concentrations of reproductive hormones and oocyte-specific growth factors in follicular fluid from human small antral folliclesN Friis Wang, L S Mamsen, J Cadenas, et al.
HIV Medicine|January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) studyM Law, N Friis-Møller, R Weber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2008
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction, C A Sabin, A d'Arminio Monforte, et al.
AIDS (London, England)|August 19, 2004
Cardio- and cerebrovascular events in HIV-infected personsA d'Arminio, C A Sabin, A N Phillips, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|April 9, 2026
Prevalence of an endogenous LH rise following final GnRH antagonist dose in the IVF antagonist protocolK Løssl, N Friis Wang, J W Bogstad, et al.
The Journal of Infectious Diseases|March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?E Fontas, F van Leth, C A Sabin, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
HIV Medicine|January 22, 2011
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*)K Petoumenos, S Worm, P Reiss, et al.
Human Reproduction (Oxford, England)|February 8, 2025
Impact of female age on concentrations of reproductive hormones and oocyte-specific growth factors in follicular fluid from human small antral folliclesN Friis Wang, L S Mamsen, J Cadenas, et al.
HIV Medicine|January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) studyM Law, N Friis-Møller, R Weber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 8, 2008
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction, C A Sabin, A d'Arminio Monforte, et al.
AIDS (London, England)|August 19, 2004
Cardio- and cerebrovascular events in HIV-infected personsA d'Arminio, C A Sabin, A N Phillips, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X|April 9, 2026
Prevalence of an endogenous LH rise following final GnRH antagonist dose in the IVF antagonist protocolK Løssl, N Friis Wang, J W Bogstad, et al.
The Journal of Infectious Diseases|March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?E Fontas, F van Leth, C A Sabin, et al.
HIV Medicine|April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D StudyM G Law, N Friis-Møller, W M El-Sadr, et al.
Pageof 3